The estimated Net Worth of Jian Xie is at least $17.7 million dollars as of 3 September 2024. Mr Xie owns over 1,594 units of Fulgent Genetics Inc stock worth over $7,420,448 and over the last 4 years he sold FLGT stock worth over $10,093,985. In addition, he makes $224,540 as Chief Operating Officer at Fulgent Genetics Inc.
Mr has made over 31 trades of the Fulgent Genetics Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 1,594 units of FLGT stock worth $35,004 on 3 September 2024.
The largest trade he's ever made was selling 62,000 units of Fulgent Genetics Inc stock on 9 March 2021 worth over $6,364,300. On average, Mr trades about 1,929 units every 20 days since 2020. As of 3 September 2024 he still owns at least 341,170 units of Fulgent Genetics Inc stock.
You can see the complete history of Mr Xie stock trades at the bottom of the page.
Jian Xie is the Chief Operating Officer at Fulgent Genetics Inc.
As the Chief Operating Officer of Fulgent Genetics Inc, the total compensation of Mr Xie at Fulgent Genetics Inc is $224,540. There are 5 executives at Fulgent Genetics Inc getting paid more, with Paul Kim having the highest compensation of $823,481.
Mr Xie is 55, he's been the Chief Operating Officer of Fulgent Genetics Inc since . There are 6 older and 4 younger executives at Fulgent Genetics Inc. The oldest executive at Fulgent Genetics Inc is John Bolger, 73, who is the Independent Director.
Jian's mailing address filed with the SEC is C/O FULGENT GENETICS, INC., 4399 SANTA ANITA AVENUE, EL MONTE, CA, 91731.
Over the last 8 years, insiders at Fulgent Genetics Inc have traded over $32,817,108 worth of Fulgent Genetics Inc stock and bought 1,136,382 units worth $9,558,758 . The most active insiders traders include Hanlin Gao, Ming Hsieh et Paul Kim. On average, Fulgent Genetics Inc executives and independent directors trade stock every 28 days with the average trade being worth of $848,250. The most recent stock trade was executed by Paul Kim on 3 September 2024, trading 1,674 units of FLGT stock currently worth $36,761.
mission developing flexible and affordable genetic testing that improves the everyday lives of those around us. founded in 2011, fulgent began with two simple ideas; flexibility and affordability. today, we strive to create the most effective and wide ranging tests on the market. all of this is done in the pursuit of bettering the everyday lives of our customers. we shine brightest when meaningful relationships, passion, and purpose come together. why fulgent? we are committed to working side-by-side with every one of our clients. this is essential to a strong and successful relationship and is our core way of doing business. we have collaborated with some of the top clinicians in our field who have assisted us in creating our panels, report formatting, and improvements to our website. our approach has always been simple: provide testing based on the specific needs of clinicians and their patients. customer support our support philosophy has always been simple: answer our client's ques
Fulgent Genetics Inc executives and other stock owners filed with the SEC include: